Summary
The Common Approach endorsed by the European Parliament, the Council and the Commission in July 2012 (as attached to the Joint Statement on EU decentralised agencies signed by these three institutions) called for the development and application in all EU decentralised agencies of a coherent policy on preventing and managing conflicts of interest concerning the members of the Management Board, whether or not they sit in a personal capacity, the members of the Scientific Committee and the agencies’ Directors.
For this purpose and in line with this Common Approach, the Commission adopted ‘Guidelines on the prevention and management of conflicts of interest in EU decentralised agencies’ on 10 December 2013. These Guidelines aim at supporting agencies, by providing a set of principles and tools that they should consider in order to develop their own conflict-of-interest policy, with due consideration given to the specific context in which each one of them operates, as well as their degree of exposure to the risk of conflict of interest.
On this basis the EMCDDA Management Board adopted the EMCDDA policy for the prevention and management of conflicts of interest at its meeting of 5 December 2014.
On 2 August 2018, the revised EU Financial Regulation entered into force. It has further improved the existing measures to protect the EU financial interests, and strengthened the rules on conflicts of interest.
In this context the European Commission issued new ‘Guidance on the avoidance and management of conflicts of interest under the Financial Regulation’ (Official Journal of the European Union 2021/C 121/01), that aims to raise awareness and promoting a uniform interpretation and application of the rules on avoidance of conflicts of interest.
The Regulation (EU) 2023/1322 of the European Parliament and of the Council on the European Union Drugs Agency (EUDA), which entered into application on 2 July 2024, states the following:
Article 22(2) of the EUDA Regulation:
‘The members of the Agency’s administrative and management structure shall not have any financial or other interests that could affect their impartiality. They shall act in the public interest and carry out activities in an independent, impartial and transparent manner. They shall make an annual declaration of their interests, which may be accessible upon request.’
Article 24(i) of the EUDA Regulation:
‘The Management Board shall adopt rules for the prevention and management of conflicts of interest in respect of its members, the members of the Executive Board, the members of the Scientific Committee and the members of the Reitox network, and of seconded experts and other staff not employed by the Agency as referred to in Article 44, and shall publish annually on the Agency’s website the declaration of interests of the Management Board members.’
On this basis the document below presents the EUDA policy for the prevention and management of conflicts of interest.
Download as PDF
EUDA policy for the prevention and management of conflicts of interest
PDF files are made available as a convenience. In cases where the EUDA is not the originator of the document, please be aware that any PDFs available on this page may not be authoritative or there may be more recent versions available. While we make every effort to ensure that these files are definitive, before using or citing them, we recommend that you consult the publisher's website or contact the author(s) to check for more recent versions.
- Open access
- English